PLEDGE NOW
The Mega Costs Of Miracle Drugs

Super expensive miracle drugs.  How much can we afford to pay? Plus, a look at a powerful new painkiller making headlines.

In this Saturday, Aug. 11, 2012 file photo, employees of the New Hampshire state health department set up a temporary clinic at the the middle school in Stratham, N.H., to test hundreds of people for hepatitis C related to an outbreak at nearby Exeter Hospital. A new drug, Sovaldi, is said to successful treat more than 90 percent of Hepatitis C patients. (AP)

In this Saturday, Aug. 11, 2012 file photo, employees of the New Hampshire state health department set up a temporary clinic at the the middle school in Stratham, N.H., to test hundreds of people for hepatitis C related to an outbreak at nearby Exeter Hospital. A new drug, Sovaldi, is said to successful treat more than 90 percent of Hepatitis C patients. (AP)

We all know drugs can be super-expensive in the USA, but how about this for a pharmacy bill?  The hottest new treatment for hepatitis C costs $1,000 a pill.  Eighty-four thousand dollars for a twelve-week course.  About three million Americans have hepatitis C.  Do the math.  Treat all those people and the whole system topples over.  Billions and billions.  But our system has no automatic brakes.  Americans want the best in drug therapies.  But as new drug prices climb, how far can we go?  When do we hit a wall?  Is it now?  This hour On Point:  super-expensive drugs, and the American way of health care.

— Tom Ashbrook

Guests

James Surowiecki, staff writer at the New Yorker, where he writes the financial page.

Dr. Steve Miller, chief medical officer of the pharmacy benefit management firm, Express Scripts.

Patricia Danzon, professor of health care management at the University of Pennsylvania’s Wharton School of Business.

From Tom’s Reading List

New Yorker: Biotech’s Hard Bargain — “In December the F.D.A. approved the first in a new wave of hep-C drugs, Gilead’s Sovaldi. This is huge news—not just in medicine but on Wall Street. Vamil Divan, a drug-industry analyst at Credit Suisse, told me, ‘Sovaldi and the other new hep-C drugs are great drugs for a tough disease.’ Sovaldi can cure ninety per cent of patients in three to six months, with only minor side effects. There’s just one catch: a single dose of the drug costs a thousand dollars, which means that a full, twelve-week course of treatment comes to more than eighty grand.”

NPR: Costly Hepatitis C Pill Shreds Drug Industry Sales Record — “To make the case for Sovaldi’s price, Gilead put together a chart of hepatitis C treatment costs for a variety of medicines. A combination of Sovaldi, a common form of interferon and the antiviral ribavirin, would cost $94,078 for treatment that would last 12 weeks. Other drug combinations that would take longer for treatment ranged from $64,825 to $106,673.”

New England Journal of Medicine: The Costs of Success — “Unfortunately, not all barriers to treatment will be lifted. The major limitation remaining will be economic. The current cost of a 12-week regimen of sofosbuvir alone is $84,000, or $1,000 per tablet. The addition of ledipasvir will add to the costs, and these estimates do not include expenses for diagnostic assays, monitoring, and physician visits.”

Painkiller Zohydro Sparks Addiction Concerns Anew

Lisa Girion, health and investigative reporter for the Los Angeles Times. (@lisagirion)

Boston Globe: Drugmakers dual role as friend, foe — “Doctors prescribe way too many powerful painkillers in this country. The skyrocketing overdoses are mirrored by rising prescriptions for Oxycodone, Vicodin, and other opioids, especially for middle-aged people in chronic pain. Adding another powerful painkiller to an already saturated market, especially one that is easily crushed and snorted, means more prescriptions, more abuse, and, inevitably, more deaths.”

Please follow our community rules when engaging in comment discussion on this site.
ONPOINT
TODAY
May 2, 2016
A man walks on the rail tracks of a train station turned into a makeshift camp crowded by migrants and refugees, at the northern Greek border point of Idomeni, Greece, Friday, April 29, 2016. Many thousands of migrants remain at the Greek border with Macedonia, hoping that the border crossing will reopen, allowing them to move north into central Europe. (AP Photo/Gregorio Borgia)

A top former US diplomat says refugees and tribalism are pulling Europe apart and that the US needs to get involved- to help Europe by helping refugees.

May 2, 2016
ADVANCE FOR MONDAY, MAY 2, 2016 AND THEREAFTER - In this April 19, 2016 photo, Laurie Millan, a para-professional and tutor, works with a student during an after school tutoring session at San Francisco International High School, in San Francisco. While some districts in numerous states have discouraged migrant minors from Central America from enrolling in their schools, the school accommodated its youths by rewriting young-adult novels at a basic level to spark the newcomers' interest in reading.  (AP Photo/Jeff Chiu)

Is grit the secret sauce that drives success? More important than both talent and intellect? We’re talking the power and limits of grit.

RECENT
SHOWS
Apr 29, 2016
Screengrab from the #MorethanMean video produced by Sarah Spain and Julie Dicaro. Scroll down to view the video.

Women pushing back. A video by two female sports reporters about online harassment goes viral.

 
Apr 29, 2016
Republican presidential candidate Sen. Ted Cruz, R-Texas, joined by former Hewlett-Packard CEO Carly Fiorina waves during a rally in Indianapolis, Wednesday, April 27, 2016, when Cruz announced he has tapped Fiorina to serve as his running mate. (AP Photo/Michael Conroy)

Trump and Hillary wins. Bernie lays off. Cruz chooses Carly. Beyonce drops “Lemonade.” Our weekly news roundtable goes beyond the headlines.

On Point Blog
On Point Blog
‘Embedded’: How Violent Gangs Are Terrorizing El Salvador
Thursday, Apr 14, 2016

NPR’s Kelly McEvers on her reporting in El Salvador for the podcast Embedded, and how gang killings brought San Salvador’s bus service to a halt.

More »
Comment
 
That Cheap Dress On Facebook? It Isn't Worth It
Monday, Apr 11, 2016

Know those shockingly cheap clothes you see advertised on Facebook? There’s a catch.

More »
Comment
 
The Boston Globe Imagines — And Rejects — A President Trump Front Page
Monday, Apr 11, 2016

The Boston Globe editorial page imagines — and rejects — President Donald Trump.

More »
Comment